Search

Your search keyword '"Feras Alissa"' showing total 3 results
Start Over Author "Feras Alissa" Publisher elsevier bv
3 results on '"Feras Alissa"'

1. Improvements in intestine transplantation

Author

Chethan Ashokkumar, Feras Alissa, Beverly Kosmach, Jeffrey A. Rudolph, Ajai Khanna, Dale Zecca, Rakesh Sindhi, Neslihan Celik, Armando Ganoza, George V. Mazariegos, Renee Brown-Bakewell, Qing Sun, Geoffrey Bond, Kaitlin Stanley, and Kyle Soltys

Subjects
Short Bowel Syndrome, medicine.medical_specialty, Intestine transplantation, business.industry, Intestine transplant, 030230 surgery, Immune monitoring, Nutritional failure, Quality Improvement, Intestines, Transplantation, 03 medical and health sciences, Treatment Outcome, surgical procedures, operative, 0302 clinical medicine, Pediatrics, Perinatology and Child Health, Humans, Medicine, 030211 gastroenterology & hepatology, Surgery, Child, business, Intensive care medicine, Digestive System Surgical Procedures
Abstract

Transplantation of the intestine in children has presented significant challenges even as it has become a standard to treat nutritional failure due to short gut syndrome. These challenges have been addressed in part by significant improvements in short and long-term care. Noteworthy enhancements include reduced need for intestine transplantation, drug-sparing immunosuppressive regimens, immune monitoring, and improved surveillance and management of PTLD and non-adherence.

Published
2018
Full Text
View/download PDF

2. Su2006 MEGACYSTIS MICROCOLON INTESTINAL HYPOPERISTALSIS SYNDROME: A CASE SERIES WITH LONG TERM FOLLOW UP AND PROLONGED SURVIVAL

Author

Armando Ganoza, Jeffrey A. Rudolph, Feras Alissa, Tracey Presel, Kimberly Ackerman, Dale King, Jane Anne Yaworski, Wednesday Marie A. Sevilla, Krishnapriya Marangattu Prathapan, and Vikram K. Raghu

Subjects
medicine.medical_specialty, Hepatology, business.industry, Long term follow up, Internal medicine, Gastroenterology, medicine, Megacystis, Microcolon, business, medicine.disease, Intestinal hypoperistalsis
Published
2020
Full Text
View/download PDF

3. Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia

Author

Benjamin L. Shneider, John C. Magee, Saul J. Karpen, Elizabeth B. Rand, Michael R. Narkewicz, Lee M. Bass, Kathleen Schwarz, Peter F. Whitington, Jorge A. Bezerra, Nanda Kerkar, Barbara Haber, Philip Rosenthal, Yumirle P. Turmelle, Jean P. Molleston, Karen F. Murray, Vicky L. Ng, Kasper S. Wang, Rene Romero, Robert H. Squires, Ronen Arnon, Averell H. Sherker, Jeffrey Moore, Wen Ye, Ronald J. Sokol, Estella Alonso, Elizabeth Kaurs, Sue Kelly, Kevin Bove, James Heubi, Alexander Miethke, Greg Tiao, Julie Denlinger, Andrea Ferris, Amy Feldman, Cara Mack, Frederick Suchy, Shikha Sundaram, Johan Van Hove, Michelle Hite, Susanna Kantor, Todd Miller, Julia Smith, Becky VanWinkle, Kathleen Loomes, Henry Lin, David Piccoli, Pierre Russo, Nancy Spinner, Lindsay Brown, Emily Elgert, Jessi Erlichman, Feras Alissa, Douglas Lindblad, George Mazariegos, Roberto Ortiz-Aguayo, David Perlmutter, Rakesh Sindhi, Veena Venkat, Jerry Vockley, Kathy Bukauskas, Adam Kufen, Madeline Schulte, Laura Bull, Shannon Fleck, Camille Langlois, Jeffery Teckman, Vikki Kociela, Stacy Postma, Kathleen Harris, Molly Bozic, Girish Subbarao, Beth Byam, Ann Klipsch, Cindy Sawyers, Simon Horslen, Evelyn Hsu, Kara Cooper, Melissa Young, Binita Kamath, Maria DeAngelis, Constance O'Connor, Krista VanRoestel, Arpita Parmar, Claudia Quammie, Kelsey Hung, Stephen Guthery, Kyle Jensen, Ann Rutherford, Nanda Kerker, Sonia Michail, Danny Thomas, Catherine Goodhue, Nikita Gupta, Mariam Vos, Liezl de la Cruz-Tracey, Dana Hankerson-Dyson, Rita Tory, Taieshia Turner-Green, Allison Wellons, Mary Brandt, Milton Finegold, Sanjiv Harpavat, Paula Hertel, Daniel Leung, Loriel Liwanag, Richard Thompson, Sherry Brown, Edward Doo, Jay Hoofnagle, Sherry Hall, Rebecca Torrance, Jameisha Brown, Kimberly Kafka, Robert Merion, and Cathie Spino

Subjects
medicine.medical_specialty, business.industry, medicine.medical_treatment, Area under the curve, Liver transplantation, medicine.disease, Hepatoportoenterostomy, Gastroenterology, Surgery, 03 medical and health sciences, Liver disease, 0302 clinical medicine, Multicenter study, Biliary atresia, 030225 pediatrics, Internal medicine, Pediatrics, Perinatology and Child Health, medicine, Biomarker (medicine), 030211 gastroenterology & hepatology, business, Prospective cohort study
Abstract

Objectives To prospectively assess the value of serum total bilirubin (TB) within 3 months of hepatoportoenterostomy (HPE) in infants with biliary atresia as a biomarker predictive of clinical sequelae of liver disease in the first 2 years of life. Study design Infants with biliary atresia undergoing HPE between June 2004 and January 2011 were enrolled in a prospective, multicenter study. Complications were monitored until 2 years of age or the earliest of liver transplantation (LT), death, or study withdrawal. TB below 2 mg/dL (34.2 μM) at any time in the first 3 months (TB Results Fifty percent (68/137) of infants had TB P P P P P = .0002), LT (OR 12.4, 95% CI 5.3-28.7, P P Conclusions Infants whose TB does not fall below 2.0 mg/dL within 3 months of HPE were at high risk for early disease progression, suggesting they should be considered for LT in a timely fashion. Interventions increasing the likelihood of achieving TB Trial registration ClinicalTrials.gov: NCT00061828 and NCT00294684.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results